Adjuvant docetaxel given to men who underwent radiotherapy for intermediate- or high-risk prostate cancer and who were on androgen deprivation therapy did not lower their risk of PSA progression, a study found.
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival.
[Journal of Hepatocellular Carcinoma]
An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide.
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies.
Antihormone treatment also recommended in conjunction with radiotherapy.
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant.
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
[OncoTargets and Therapy] A review of the role of radiation therapy and potential prognostic factors for selecting patients for more radical treatment.
[Breast Cancer: Targets and Therapy] A review of the potential of immunotherapy along and in combination with standard therapies for breast cancer, in particularly HER2-positive expressing subtypes.
